SCHEMBL14435390

SCHEMBL14435390

Clc1cccc(N(c2cncnc2)C(c2cccnc2)c2cccnc2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.38
CYP2A6 P11509 1/20 0.37
CFTR P13569 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
GOPC Q9HD26 1/20 0.35
KCNA5 P22460 8/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
KCND3 Q9UK17 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP3A5 P20815 1/20 0.31
LMNA P02545 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.31
GRM5 P41594 1/20 0.30
KCNH2 Q12809 1/20 0.30
MAPT P10636 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4461625 0.92 CYP19A1 (0.40) CYP19A1CYP2A6CFTRSLC6A2SLC6A4
SCHEMBL4458972 0.88 CFTR (0.41) CYP19A1CFTRSLC6A2SLC6A4SLC6A3
SCHEMBL4462104 0.88 CFTR (0.42) CYP19A1CFTRSLC6A2SLC6A4SLC6A3
SCHEMBL4470641 0.84 POLB (0.37) CYP19A1CFTRSLC6A2SLC6A4SLC6A3
SCHEMBL4458274 0.81 CYP19A1 (0.49) CYP19A1KCNA5CYP3A4CYP3A5L3MBTL1
SCHEMBL4459552 0.80 KCNA5 (0.42) CYP19A1KCNA5CYP3A4GRM5KCNH2
SCHEMBL4459564 0.79 CYP19A1 (0.36) CYP19A1KCNA5
SCHEMBL4470602 0.79 KCNA5 (0.35) CYP19A1KCNA5
SCHEMBL4463302 0.78 TAAR1 (0.35) KCNA5CYP3A4CYP3A5
SCHEMBL4453054 0.78 TAAR1 (0.38) KCNA5KCND3CYP3A4CYP3A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007089679-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2007-08-09 WO disclosed